Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis

EBioMedicine. 2016 Feb 9;4:7-8. doi: 10.1016/j.ebiom.2016.02.016. eCollection 2016 Feb.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Cyclic AMP
  • Humans
  • Mycobacterium tuberculosis
  • Phosphodiesterase 3 Inhibitors
  • Phosphodiesterase 4 Inhibitors / therapeutic use
  • Phosphodiesterase 5 Inhibitors
  • Phosphodiesterase Inhibitors*
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Phosphodiesterase 3 Inhibitors
  • Phosphodiesterase 4 Inhibitors
  • Phosphodiesterase 5 Inhibitors
  • Phosphodiesterase Inhibitors
  • Cyclic AMP